Webinar Date/Time: Thursday, October 26th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Join IQVIA Technologies to discuss developing fair market value (FMV) for investigator grants and budgeting for clinical trials in today's tumultuous environment.
Register Free: https://www.appliedclinicaltrialsonline.com/act/budgeting-strategies
Event overview
While inflation has slowed after reaching a four-decade high last summer, prices remain high. Additionally, attrition rates at clinical research sites still exceed those of most other industries. Taken together, these two market conditions make developing fair marketing value (FMV) for investigator grants a challenging process. Join IQVIA Technologies for a topical discussion on budgeting in today’s tumultuous environment.
Three key take-aways
Speaker:
Jesse Glass
Data Science Manager, GrantPlan Development
IQVIA Technologies
Jesse Glass received his PhD in Machine Learning from Temple University in 2020 and his undergraduate degree in Economics from Tulane University in 2008. His work is focused on integrating Probabilistic Models for improved data quality control to present data with a richer tapestry. His work also includes incorporating text processing to streamline user experience and advanced modeling capabilities.
Register Free: https://www.appliedclinicaltrialsonline.com/act/budgeting-strategies
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
2 Commerce Drive
Cranbury, NJ 08512